North America accounted for 46% of global cannabidiol oil (CBD oil) revenue in 2025, worth USD 4.69 billion, and Contrive Datum Insights projects that regional total will reach USD 12.92 billion by 2034. No other region starts anywhere near that share.
The finding comes from a new Contrive Datum Insights study covering the global cannabidiol oil market by type, application, distribution channel, formulation and end use, with a regional forecast running through 2034. The global market is sized at USD 10.2 billion in 2025, rises to USD 11.65 billion in 2026, and reaches USD 30.55 billion by 2034, a compound annual growth rate of 12.81% across the forecast period.
CBD oil is a cannabinoid extract drawn from hemp or marijuana plants. It sells as a standalone tincture and also as an ingredient blended into pharmaceuticals, food and beverage products, and cosmetics. Buyers range from individual consumers seeking wellness and pain relief to manufacturers sourcing it in bulk for their own branded goods, plus healthcare and veterinary practitioners who dispense it to patients and animals.
Europe Closes Part of the Gap
Europe's share of global revenue rises from 27% in 2025 to 27.9% in 2034, with regional revenue growing from USD 2.75 billion to USD 8.52 billion. Middle East and Africa stays flat at 4% of global revenue in both years, the smallest region the study covers. The United States alone accounts for USD 3.99 billion of 2025 revenue, 39.12% of the global total, and remains the largest single country market tracked.
The Segment Picture, and What It Means for the Leader
Hemp-derived material supplies 72% of 2025 revenue, USD 7.34 billion, and stays the largest type line through 2034, though its share narrows to 65.7%. Marijuana-derived is the fastest-growing line in the study at 16.24% a year, taking its share of revenue from 20% to 26.3% and its value from USD 2.04 billion to USD 8.03 billion. Elsewhere in the segmentation, Cosmetics leads applications in 2025 at 20% of revenue while Pharmaceuticals grows fastest at 15.15%; Online Retail leads distribution channels at 24% of 2025 revenue; Full Spectrum leads formulations at 48% while Broad Spectrum grows fastest at 14.17%; and Personal/Retail Use leads end-use categories at 62% while Veterinary Use grows fastest at 15.76%.
None of that guarantees North America keeps its current lead. The study's bear case, built on tighter regulatory restrictions and continued hemp oversupply pricing pressure, holds the 2034 global total to USD 26.88 billion instead of USD 30.55 billion; its bull case, built on faster regulatory legalization and accelerated mainstream retail placement, lifts the total to USD 34.22 billion. Under either scenario, the fastest dollar growth tracks to Marijuana-derived product, not to the type or the region that already leads. A region that starts ahead on share still has to grow near 12.81% a year just to hold that share as the rest of the market scales.
The report segments the market by type, application, distribution channel, formulation and end use, with revenue and a growth rate for every line in every year from 2020 to 2034, and covers all five regions with country-level detail, the competitive landscape and the research methodology behind each estimate. It is delivered as a PDF; a free sample is available on request.